Quick answer: Acne, psoriasis, eczema, rosacea, hair loss, and premature skin aging share common upstream drivers — gut dysbiosis, insulin resistance, hormonal imbalances, and chronic inflammation — that functional medicine can address at root cause, producing skin transformation that topical treatments and antibiotics cannot achieve.
The skin is the body’s largest organ and its most visible biomarker of internal health. Dermatological conditions conventionally treated with antibiotics, corticosteroids, retinoids, and biologics frequently recur when treatment stops because the systemic drivers are never addressed. Functional dermatology investigates the gut-skin axis, hormonal milieu, nutrient deficiencies, and inflammatory signals that determine skin health — producing durable improvement rather than symptom suppression.
The Gut-Skin Axis: How Gut Health Drives Skin Conditions
The connection between gut microbiome and skin health — the “gut-skin axis” — was clinically observed by Stokes and Pillsbury in 1930 and has now been extensively validated molecularly. Gut dysbiosis drives systemic inflammation through multiple pathways: LPS from gram-negative bacteria crossing a leaky gut activates TLR4/NF-κB in skin keratinocytes and sebocytes; gut microbial SCFA deficiency reduces skin barrier function; and gut serotonin production (90% of total body serotonin) affects sebaceous gland activity through neuroendocrine pathways.
Bowe & Logan (2011, Gut Pathogens) synthesis: patients with acne have significantly higher rates of intestinal permeability, SIBO, and H. pylori infection than non-acne controls. H. pylori eradication produces significant improvement in rosacea — Rebora et al. (1994, Dermatology) showed 72% of rosacea patients improved after H. pylori eradication, with recurrence upon reinfection. SIBO is present in 46% of rosacea patients vs. 5% controls (Parodi et al. 2008, Clinical Gastroenterology and Hepatology), and rifaximin SIBO treatment produced complete rosacea resolution in 71% of SIBO-positive patients.
Bifidobacterium longum NCC3001 supplementation reduced skin sensitivity, decreased transepidermal water loss, and improved skin hydration in a randomized trial (Benyacoub 2005) — directly demonstrating probiotic effects on skin barrier function. Lactobacillus plantarum reduces skin water loss and increases skin ceramide and collagen expression (Lee 2015, Journal of Microbiology and Biotechnology). Probiotic supplementation: Lactobacillus acidophilus + Lactobacillus bulgaricus combination reduced acne lesion count by 40% over 12 weeks in RCT (Kim 2010, Nutrition).
Acne Vulgaris: Insulin, IGF-1, and Hormonal Drivers
Acne is fundamentally a disease of insulin resistance, androgen excess, and gut dysbiosis — not primarily a bacterial disease (the role of Cutibacterium acnes is as a commensal disrupted by inflammation, not the primary pathogen). Cordain et al. (2002, Archives of Dermatology) published the landmark study documenting zero acne prevalence in the Kitavan island population and the Aché hunter-gatherers of Paraguay — populations eating no refined carbohydrates or dairy — providing strong evidence for dietary causation.
The IGF-1/insulin pathway is the central molecular driver. Elevated insulin → increased IGF-1 → activation of mTORC1 → increased sebaceous lipogenesis, keratinocyte proliferation, and reduced follicular apoptosis. Dairy (particularly skim milk) contains bioactive IGF-1 and increases endogenous IGF-1 by 20–30% — Adebamowo et al. (2005, Journal of the American Academy of Dermatology) Harvard cohort study (47,355 women) found highest skim milk intake associated with 44% higher severe acne prevalence. Di Landro et al. (2012, Journal of the American Academy of Dermatology) replicated this in an Italian case-control study: dairy and high glycemic load food associated with significantly increased acne odds ratio.
The AGTC (A-G-T-C) dietary acne protocol: Anti-inflammatory, low-Glycemic index, dairy-Toxin elimination (dairy and high-IGF1 foods), Cortisol management. Smith et al. (2007, American Journal of Clinical Nutrition) RCT — 43 young men randomized to low-glycemic vs. conventional diet for 12 weeks: low-glycemic diet reduced total lesion count by 21.9 vs. 13.8 (p=0.01), reduced free androgen index, reduced IGF-1, and increased sex hormone binding globulin. Zinc supplementation (zinc sulfate 400 mg or zinc gluconate 30 mg elemental zinc) has meta-analysis support (Dreno 2001, Dermatology) comparable to antibiotic tetracycline for mild-moderate acne, with anti-5-alpha reductase and anti-inflammatory mechanisms.
Psoriasis: Systemic Inflammation and Metabolic Links
Psoriasis is classified as a systemic immune-mediated disease — not a skin-limited condition. The IL-17/IL-23 axis drives keratinocyte hyperproliferation, producing the characteristic plaques, while simultaneously increasing cardiovascular risk (psoriasis doubles MI risk — Gelfand 2006 JAMA, 130,000 patient cohort), metabolic syndrome risk (3× higher prevalence), depression risk (39% higher), and non-alcoholic fatty liver disease risk (9× higher). Addressing psoriasis functionally requires treating it as a systemic inflammatory syndrome.
The psoriasis microbiome: Fahlén et al. (2012) and Tett et al. (2017) documented gut microbiome dysbiosis in psoriasis with depletion of Faecalibacterium prausnitzii (anti-inflammatory SCFA producer) and enrichment of Candida, Malassezia, and pro-inflammatory bacteria. F. prausnitzii depletion correlates with IL-17 elevation and psoriasis severity. Dietary interventions: Mediterranean diet reduces psoriasis severity scores (PASI) significantly — Barrea et al. (2015, Journal of Translational Medicine) found inverse correlation between Mediterranean diet adherence and PASI scores. Gluten elimination in HLA-DQ2/DQ8 positive psoriasis patients (antigliadin IgA positive subset) reduces disease activity — Michaëlsson et al. (2000, Lancet) randomized 27 psoriasis patients with high antigliadin antibodies: gluten-free diet for 3 months significantly reduced PASI scores vs. normal diet.
Omega-3 fatty acids reduce leukotriene B4 (LTB4) — the primary chemoattractant for neutrophils in psoriatic plaques — by competitively replacing arachidonic acid. Mayser et al. (1998, British Journal of Dermatology) RCT: IV omega-3 (5.4g EPA/day) significantly reduced PASI scores vs. omega-6 control. Oral EPA+DHA at 3–4g/day shows moderate PASI reduction in multiple smaller RCTs. Vitamin D3 (high-dose oral, 35,000 IU/day for 6 months under supervision) produced dramatic psoriasis improvement in a Brazilian case series (Finamor 2013, Dermato-Endocrinology), consistent with topical vitamin D analogs (calcipotriol) being standard psoriasis treatment — suggesting systemic vitamin D optimization may replicate topical benefits at lower doses.
Rosacea: SIBO, Mast Cells, and Vascular Dysregulation
Rosacea — characterized by facial erythema, telangiectasia, papulopustules, and ocular involvement — has a fundamentally different pathophysiology than acne. The Demodex folliculorum mite (present at 10× higher density in rosacea vs. normal skin), SIBO-derived systemic inflammation, mast cell activation, and autonomic vascular dysregulation are the primary drivers. Steinhoff et al. (2011, Nature Reviews Drug Discovery) established TRP channels (TRPV1, TRPA1) on facial sensory neurons as central mediators of vasodilation and neurogenic inflammation in rosacea.
Gut-rosacea connection: beyond the SIBO data, H. pylori eradication studies, and intestinal permeability evidence, Drago et al. (2016, Journal of the European Academy of Dermatology) found that small intestinal cleansing with rifaximin produced significant rosacea clearance — and recurrence upon SIBO recurrence. Identifying and treating SIBO (lactulose breath test, 3-hour protocol) with rifaximin 550 mg twice daily × 14 days is a first-line functional rosacea intervention. Sun avoidance, heat triggers, and alcohol all worsen rosacea through TRP channel activation — these should be systematically catalogued through a rosacea trigger diary.
Alopecia and Hair Loss: Iron, Thyroid, and DHT
Hair loss has multiple functional root causes that require systematic evaluation: iron deficiency (serum ferritin below 30–40 ng/mL is the threshold for hair cycling impairment — Rushton 2002, Clinical and Experimental Dermatology), thyroid dysfunction (both hypothyroidism and hyperthyroidism cause telogen effluvium — TSH optimization to 1–2 mU/L essential), DHT-driven androgenetic alopecia (5-alpha reductase activity converts testosterone to DHT in scalp follicles), nutrient deficiencies (zinc, biotin, amino acids — especially lysine), and autoimmune alopecia areata (Th1/Th17-mediated attack on hair follicle immune privilege).
Ferritin optimization is the most undertreated reversible cause of hair loss. Phytotherapy trial Rushton 2002: 90 women with diffuse hair loss, serum ferritin <40 ng/mL randomized to iron supplementation + L-lysine vs. placebo — significant reduction in hair shedding with normalization of ferritin. Thyroid: autoimmune thyroiditis (Hashimoto's) produces thyroid hormone fluctuations that cause cyclical telogen effluvium — TPO antibody reduction with selenium (Gärtner 2002) directly improves hair cycling. Saw palmetto — 5-alpha reductase inhibitor — Rossi et al. (2012, Journal of Alternative and Complementary Medicine) RCT: saw palmetto 200 mg/day vs. 1 mg finasteride for 24 months produced 38% improvement in androgenetic alopecia — essentially comparable to finasteride without sexual side effects.
Skin Aging: Collagen, Oxidative Stress, and Glycation
Skin aging is driven by intrinsic mechanisms (telomere attrition, mitochondrial dysfunction, collagen crosslinking by AGEs) and extrinsic mechanisms (UV damage, air pollution, cigarette smoke). Advanced glycation end products (AGEs) — formed by non-enzymatic glycation of proteins in high-glucose conditions — crosslink collagen fibers, reducing elasticity and increasing yellowing. Dietary restriction of exogenous AGEs (reduction of dry-heat cooking methods) and insulin resistance treatment are the most impactful anti-AGE skin interventions.
Collagen peptide supplementation: Proksch et al. (2014, Skin Pharmacology and Physiology) RCT — 69 women aged 35–55 supplemented with bioactive collagen peptides 2.5g or 5g daily for 8 weeks — showed significant improvement in skin elasticity (skin recoil time), with residual effects 4 weeks after supplementation ended. Bolke et al. (2019, Nutrients) RCT confirmed collagen + hyaluronic acid + vitamin C supplementation significantly increased skin hydration and reduced wrinkle depth after 12 weeks. The mechanism: collagen peptide fragments (particularly Pro-Hyp and Hyp-Gly dipeptides) reach the dermis intact after absorption, stimulating fibroblast collagen synthesis by 4–6 fold in culture studies.
Vitamin C (ascorbate) is essential for collagen hydroxylation — the post-translational modification that provides tensile strength. Skin Vitamin C concentrations decline 70% with photoaging. Topical and oral Vitamin C: Moores (2013, Nutrients) demonstrated that oral vitamin C supplementation prevents UV-induced oxidative DNA damage and reduces sunburn cell formation. Astaxanthin — the carotenoid antioxidant from marine algae — reduces UV-induced skin damage by quenching singlet oxygen, with Yamashita (2002, Carotenoid Science) showing 7.7 mg/day astaxanthin for 8 weeks improved skin moisture and elasticity. Polypodium leucotomos extract (Heliocare) — a fern extract — in Middelkamp-Hup (2004, Journal of the American Academy of Dermatology) RCT demonstrated significant reduction in UV-induced erythema and PUVA-induced DNA damage.
Functional Dermatology Testing and Treatment Protocol
Comprehensive functional dermatology panel: serum ferritin (target >40 ng/mL for hair, >70 for acne), comprehensive thyroid panel (TSH, free T3, free T4, TPO antibodies — Hashimoto’s drives multiple skin conditions), hormonal panel (testosterone free/total, DHEA-S, DHT, estradiol, progesterone, cortisol — DUTCH Complete), fasting insulin and HOMA-IR (sebaceous gland activity directly regulated by insulin), HbA1c and fasting glucose (glycation assessment), 25-OH vitamin D (target 60–80 ng/mL for immune regulation), zinc RBC, comprehensive microbiome testing (GI-MAP for SIBO, dysbiosis, H. pylori), antigliadin IgA (for psoriasis/dermatitis herpetiformis), and IgE RAST panel for identified skin triggers.
The 5-R gut-skin axis restoration protocol: Remove dietary triggers (dairy, high-glycemic foods, identified sensitivities), Replace digestive support (HCL + pepsin, digestive enzymes — low stomach acid commonly underlies both acne and rosacea), Reinoculate with targeted probiotics (Lactobacillus acidophilus + rhamnosus + Bifidobacterium longum), Repair the gut barrier (zinc carnosine 75 mg twice daily, L-glutamine 10g/day, bone broth collagen, butyrate), and Rebalance hormones and nutrients (target zinc, vitamin D, iron, omega-3 deficiencies, correct insulin resistance). This protocol produces measurable skin improvement within 6–12 weeks in most patients with acne, rosacea, and eczema.
Ready to address the root causes of your skin condition rather than chasing symptoms with topical treatments and antibiotics? The Private Practice offers comprehensive functional dermatology consultations with advanced testing. Call (810) 206-1402 to schedule your skin health evaluation.
Can acne be cured with diet alone?
Strong evidence supports diet as a primary driver of acne, not merely an aggravating factor. Cordain et al. (2002, Archives of Dermatology) documented zero acne in populations eating no refined carbohydrates or dairy. Smith et al. (2007, American Journal of Clinical Nutrition) RCT found a low-glycemic index diet reduced total acne lesion count by 21.9 vs. 13.8 with conventional diet (p=0.01) over 12 weeks, with parallel reductions in IGF-1 and free androgens. Dairy elimination reduces endogenous IGF-1 by 20–30%. For many patients, eliminating high-glycemic foods and dairy produces 50–80% acne improvement within 8–12 weeks. Adding zinc supplementation (30 mg elemental zinc), omega-3 anti-inflammatory support, and gut microbiome restoration addresses the remaining drivers for most cases of mild-moderate acne.
What is the gut-skin axis?
The gut-skin axis is the bidirectional relationship between intestinal microbiome composition, gut barrier integrity, and skin health. Gut dysbiosis drives skin disease through: (1) intestinal permeability allowing bacterial LPS into the bloodstream, activating TLR4 inflammation in skin cells; (2) SCFA deficiency reducing skin ceramide production and barrier function; (3) SIBO producing systemic inflammation that manifests as rosacea, acne, and eczema; and (4) altered serotonin production affecting sebaceous gland neuroendocrine regulation. Parodi et al. (2008, Clinical Gastroenterology and Hepatology) found SIBO in 46% of rosacea patients, and SIBO treatment with rifaximin produced complete rosacea clearance in 71% of SIBO-positive patients — the most striking direct demonstration of the gut-skin axis in human clinical data.
What nutritional deficiencies cause hair loss?
The four most common nutritional causes of hair loss: (1) Iron deficiency — ferritin below 30–40 ng/mL impairs hair follicle cycling; Rushton (2002, Clinical and Experimental Dermatology) showed iron + L-lysine supplementation significantly reduced shedding in iron-deficient women with diffuse hair loss. (2) Thyroid dysfunction — both hypothyroidism and Hashimoto’s fluctuation cause telogen effluvium; selenium (200 mcg/day) reduces TPO antibodies and stabilizes thyroid function. (3) Zinc deficiency — zinc inhibits 5-alpha reductase and supports keratin synthesis; serum zinc below 70 mcg/dL is associated with alopecia. (4) Amino acid deficiency, particularly L-lysine and L-methionine — essential for keratin structure and cannot be synthesized from other amino acids, requiring adequate protein intake (1.2–1.6 g/kg/day).
Does psoriasis improve with diet?
Yes — multiple dietary interventions produce significant PASI (Psoriasis Area and Severity Index) improvement. Mediterranean diet adherence shows inverse correlation with PASI scores (Barrea 2015, Journal of Translational Medicine). Gluten-free diet in antigliadin-antibody-positive psoriasis patients (HLA-DQ2/DQ8 positive subset, approximately 15% of psoriasis patients) significantly reduces PASI — Michaëlsson et al. (2000, Lancet) documented this in a randomized trial. Weight loss (caloric restriction producing 10–15% body weight reduction) reduces PASI by 40–50% in overweight patients — adipose-derived TNF-α and IL-17 drive disease activity in proportion to fat mass. Omega-3 supplementation (3–4g EPA+DHA/day) reduces LTB4, the primary psoriatic plaque chemoattractant. Alcohol elimination is strongly supported — alcohol increases keratinocyte proliferation and reduces psoriasis treatment efficacy.